Repeated infusions infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondylarthropathy: one year follow up. - Kuithof,E.; Van den Bosch,F.; Baeten,D. (Ann Rheum Dis, 2002)